Antidepressant could treat COVID-19: Fluvoxamine prevents mild cases from worsening, data suggest

摘要

The antidepressant fluvoxamine could prevent people from getting seriously ill with COVID-19, curbing hospitalizations, new data show. The results come from real-world use of the drug to treat workers at the Golden Gate Fields horse racing track in Berkeley, Calif. Of those who opted to take fluvoxamine, none got sicker, and within two weeks, symptoms cleared. In comparison, 12.5 percent of those who turned down the drug wound up hospitalized. Two people got so sick they were put on ventilators to assist with breathing, and one of them died, researchers report online February 1 in Open Forum Infectious Diseases.